Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CHRONIC MYELOID LEUKEMIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1893 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Maserati, E; Aprili, F; Vinante, F; Locatelli, F; Amendola, G; Zatterale, A; Milone, G; Minelli, A; Bernardi, F; Lo Curto, F; Pasquali, F
      Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20%of cases

      GENES CHROMOSOMES & CANCER
    2. Druker, BJ
      Current treatment approaches for chronic myelogenous leukemia

      CANCER JOURNAL
    3. Porter, DL
      The graft-versus-tumor potential of allogeneic cell therapy: an update on donor leukocyte infusions and nonmyeloablative allogeneic stem cell transplantation

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    4. Marijt, WAF; Falkenburg, JHF
      Specific T cell therapy in leukemia

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    5. Borbolla, JR; Najera, A; Arana, RM; Lopez-Hernandez, MA; Mendoza, Y; Trueba, E
      In vivo purging of peripheral blood stem cells obtained by apheresis, using high-dose chemotherapy and granulocyte colony-stimulating factor in chronic myelogenous leukemia patients

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    6. Muller, L; Provenzani, C; Pawelec, G
      Generation of chronic myelogenous leukemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumor cell cultures

      JOURNAL OF IMMUNOTHERAPY
    7. Morecki, S; Yacovlev, E; Gelfand, Y; Uzi, I; Slavin, S
      Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma

      JOURNAL OF IMMUNOTHERAPY
    8. Pawelec, G; Muller, L; Wagner, W
      MHC class II-restricted tumor antigens and CD4(+) T cells play a role in hematological malignancies as well as solid tumors

      TRENDS IN IMMUNOLOGY
    9. Campbell, JDM; Cook, G; Holyoake, TL
      Evolution of bone marrow transplantation - the original immunotherapy

      TRENDS IN IMMUNOLOGY
    10. Bhatia, V; Porter, DL
      Novel approaches to allogeneic stem cell therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    11. Dietz, AB; Litzow, MR; Bulur, PA; Vuk-Pavlovic, S
      Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells

      CYTOTHERAPY
    12. Grigg, A; Kannan, K; Schwarer, AP; Spencer, A; Szer, J
      Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation

      INTERNAL MEDICINE JOURNAL
    13. Maru, Y; Bergmann, E; Coin, F; Egly, JM; Shibuya, M
      TFIIH functions are altered by the P210BCR-ABL oncoprotein produced on thePhiladelphia chromosome

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    14. Radojkovic, M; Ristic, S; Colovic, M; Todoric, B; Krtolica, K
      Busulfan-induced loss of Ph chromosome in chronic myeloid leukemia

      MEDICAL ONCOLOGY
    15. Heisterkamp, N; Voncken, JW; Senadheera, D; Hemmeryckx, B; Gonzalez-Gomez, I; Reichert, A; Pattengale, PK; Groffen, J
      The Bcr N-terminal oligomerization domain contributes to the full oncogenicity of P190 Bcr/Abl in transgenic mice

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    16. Benthin, M; Dallmann, I; Atzpodien, J
      13cis-and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatmentin vitro

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    17. Bagg, A
      Minimal residual disease: How low do we go?

      MOLECULAR DIAGNOSIS
    18. Khoury, H; Adkins, D; Brown, R; Pence, H; Vij, R; Goodnough, LT; Westervelt, P; Trinkaus, K; Lin, HS; DiPersio, J
      Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    19. Alvarnas, JC; Linn, YC; Hope, EG; Negrin, RS
      Expansion of cytotoxic CD3(+)CD56(+) cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    20. Porter, DL; Luger, SM; Duffy, KM; Stadtmauer, EA; Laport, G; Schuster, SJ; Orloff, G; Tsai, D; McDaid, K; Kathakali, A; Leonard, DGB; Antin, JH
      Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    21. Johnson, BD; Dagher, N; Stankowski, MC; Hanke, CA; Truitt, RL
      Donor natural killer (NK1.1(+)) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    22. Dey, BR; McAfee, S; Sackstein, R; Colby, C; Saidman, S; Weymouth, D; Poliquin, C; Vanderklish, J; Sachs, DH; Sykes, M; Spitzer, TR
      Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    23. Shimoni, A; Gajewski, J; Donato, M; Martin, T; O'Brien, S; Talpaz, M; Cohen, A; Korbling, M; Champlin, R; Giralt, S
      Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    24. Carlens, S; Remberger, M; Aschan, J; Ringden, O
      The role of disease stage in the response to donor lymphocyte infusions astreatment for leukemic relapse

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    25. Honda, H; Hirai, H
      Model mice for BCR/ABL-positive leukemias

      BLOOD CELLS MOLECULES AND DISEASES
    26. Dazzi, F; Simpson, E; Goldman, JM
      Minor antigen solves major problem

      NATURE MEDICINE
    27. Vigneri, P; Wang, JYJ
      Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase

      NATURE MEDICINE
    28. Dialynas, DP; Shao, LE; Billman, GF; Yu, J
      Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood

      STEM CELLS
    29. Karlic, H; Louda, N; Pfeilstocker, M; Keil, F; Lohninger, A; Pittermann, E; Paukovits, J
      Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1 alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML)

      STEM CELLS
    30. Anasetti, C; Petersdorf, EW; Martin, PJ; Woolfrey, A; Hansen, JA
      Trends in transplantation of hematopoietic stem cells from unrelated donors

      CURRENT OPINION IN HEMATOLOGY
    31. Feinstein, L; Storb, R
      Reducing transplant toxicity

      CURRENT OPINION IN HEMATOLOGY
    32. Peggs, KS; Mackinnon, S
      Cellular therapy: donor lymphocyte infusion

      CURRENT OPINION IN HEMATOLOGY
    33. Van Etten, RA
      Pathogenesis and treatment of Ph+ leukemia: recent insights from mouse models

      CURRENT OPINION IN HEMATOLOGY
    34. Krugner-Higby, LA; Gendron, A; Laughlin, NK; Luck, M; Scheffler, J; Phillips, B
      Chronic myelocytic leukemia in a juvenile rhesus macaque (Macaca mulatta)

      CONTEMPORARY TOPICS IN LABORATORY ANIMAL SCIENCE
    35. Elizaga, J; Olvarria, E; Apperley, JF; Goldman, JM; Ward, KN
      Parainfluenza virus 3 infection after stem cell transplant: Relevance to outcome of rapid diagnosis and ribavirin treatment

      CLINICAL INFECTIOUS DISEASES
    36. Fioretos, T; Panagopoulos, I; Lassen, C; Swedin, A; Billstrom, R; Isaksson, M; Strombeck, B; Olofsson, T; Mitelman, F; Johansson, B
      Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: The first fusion gene involving BCR but not ABL

      GENES CHROMOSOMES & CANCER
    37. Vieira, SAD; Deininger, MWN; Sorour, A; Sinclair, P; Foroni, L; Goldman, JM; Melo, JV
      Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogene

      GENES CHROMOSOMES & CANCER
    38. Wang, YL; Bagg, A; Pear, W; Nowell, PC; Hess, JL
      Chronic myelogenous leukemia: Laboratory diagnosis and monitoring

      GENES CHROMOSOMES & CANCER
    39. Jeffs, AR; Wells, E; Morris, CM
      Nonrandom distribution of interspersed repeat elements in the BCR and ABLIgenes and its relation to breakpoint cluster regions

      GENES CHROMOSOMES & CANCER
    40. Ahuja, HG; Popplewell, L; Tcheurekdjian, L; Slovak, ML
      NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia

      GENES CHROMOSOMES & CANCER
    41. Van Limbergen, H; Beverloo, HB; van Drunen, E; Janssens, A; Hahlen, K; Poppe, B; Van Roy, N; Marynen, P; De Paepe, A; Slater, R; Speleman, F
      Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia

      GENES CHROMOSOMES & CANCER
    42. Chaplin, T; Jones, L; Debernardi, S; Hill, AS; Lillington, DM; Young, BD
      Molecular analysis of the genomic inversion and insertion of AF10 into MLLsuggests a single-step event

      GENES CHROMOSOMES & CANCER
    43. Thiele, J; Kvasnicka, HM
      Comparative effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    44. Banfi, A; Bianchi, G; Galotto, M; Cancedda, R; Quarto, R
      Bone marrow stromal damage after chemo/radiotherapy: Occurrence, consequences and possibilities of treatment

      LEUKEMIA & LYMPHOMA
    45. Kitzis, A; Brizard, F; Dascalescu, C; Chomel, JC; Guilhot, F; Brizard, A
      Persistence of transcriptionally silent BCR-ABL rearrangements in chronic myeloid leukemia patients in sustained complete cytogenetic remission

      LEUKEMIA & LYMPHOMA
    46. Vey, N; Balatzentko, G; LaFage, M; Sainty, D; Bouabdallah, R; Chabannon, C; Blaise, D; Gastaut, JA; Gabert, J
      Survey of early disapearance of BCR/ABL fusion transcript after allogeneicor autologous stem cell transplantation for chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    47. Ohyashiki, K; Iwama, H; Yahata, N; Tauchi, T; Kawakubo, K; Shimamoto, T; Ohyashiki, JH
      Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation

      LEUKEMIA & LYMPHOMA
    48. Ahmed, M; Dusanter-Fourt, I; Dugray, A; Dubrez, L; Novault, S; Bonnet, ML; Gisselbrecht, S; Varet, B; Solary, E; Vainchenker, W; Turhan, AG
      BCR-ABL fails to inhibit apoptosis in U937 myelomonocytic cells expressinga carboxyl-terminal truncated Stat5

      LEUKEMIA & LYMPHOMA
    49. Demirkan, F; Oztop, I; Ozsan, H; Undar, B
      Emergence of Philadelphia positive chronic myeloid leukemia in a patient with Philadelphia negative acute lymphoblastic leukemia

      LEUKEMIA & LYMPHOMA
    50. Lindauer, M; Fischer, T
      Interferon-alpha combined with cytarabine in chronic myelogenous leukemia - Clinical benefits

      LEUKEMIA & LYMPHOMA
    51. Giles, FJ; Kantarjian, H; O'Brien, S; Rios, MB; Cortes, J; Beran, M; Koller, C; Keating, M; Talpaz, M
      Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with Philadelphia chromosome positive chronic myelogenous leukemia in early chronic phase

      LEUKEMIA & LYMPHOMA
    52. Mossafa, H; Fourcade, C; Pulic, M; Jary, L; Cheze, S; Szpiro-Tapia, S; Troussard, X
      Chronic lymphocytic leukemia associated with myelodysplastic syndrome and/or chronic myeloid leukemia: Evidence for independent clonal chromosomal evolution

      LEUKEMIA & LYMPHOMA
    53. Shiratsuchi, M; Muta, K; Minami, R; Motomura, S; Suehiro, Y; Abe, Y; Shiokawa, S; Umemura, T; Fukui, T; Nishimura, J; Nawata, H
      Aberrant BCR-ABL transcript with intronic insertion in a patient with Philadelphia chromosome-positive chronic myeloid leukemia: Implications for disease progression

      LEUKEMIA & LYMPHOMA
    54. Beck, JR; Guilhot, J; Giles, FJ; Aoki, N; Wirt, DP; Guilhot, F
      Cytarabine added to interferon improves the cost-effectiveness of initial therapy for patients with early chronic phase chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    55. Nadal, E; Cervantes, F; Rosinol, L; Talarn, C; Montserrat, E
      Hypercalcemia as the presenting feature of T-cell lymphoid blast crisis ofph-positive chronic myeloid leukemia

      LEUKEMIA & LYMPHOMA
    56. Otten, HG; Van Dyk, AMC; Verdonck, LF
      Prevention of acute graft-versus-host-disease by selective depletion of T cells reactive with minor histocompatibility antigens on epithelial cells

      LEUKEMIA & LYMPHOMA
    57. Carella, AM
      Mini-ice protocol is better than high-dose hydroxyurea to mobilize Ph-negative cells in earlier phases of chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    58. Feinstein, L; Storb, R
      Nonmyeloablative hematopoietic cell transplantation

      CURRENT OPINION IN ONCOLOGY
    59. Mauro, MJ; Druker, BJ
      Chronic myelogenous leukemia

      CURRENT OPINION IN ONCOLOGY
    60. Silva, NH; Pimenta, G; Pulcheri, WA; Fournier, MV; Spector, N; Carvalho, MDGD
      Detection of messenger RNA in leukocytes or plasma of patients with chronic myeloid leukemia

      ONCOLOGY REPORTS
    61. Gebhart, E; Rosler, W; Gramatzki, M; Trautmann, U
      FISH monitoring of 100 courses of human leukemias: The cytogenetic viewpoint

      INTERNATIONAL JOURNAL OF ONCOLOGY
    62. Nadav, L; Katz, BZ
      The molecular effects of oncogenesis on cell-extracellular matrix adhesion(Review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    63. Simpson, E; Scott, D; James, E; Lombardi, G; Cwynarski, K; Dazzi, F; Millrain, M; Dyson, PJ
      Minor H antigens: genes and peptides

      EUROPEAN JOURNAL OF IMMUNOGENETICS
    64. O'Dwyer, ME; Druker, BJ
      Chronic myelogenous leukaemia - new therapeutic principles

      JOURNAL OF INTERNAL MEDICINE
    65. Petersdorf, E; Anasetti, C; Martin, PJ; Woolfrey, A; Smith, A; Mickelson, E; Malkki, M; Lin, MT; Hansen, JA
      Genomics of unrelated-donor hematopoietic cell transplantation

      CURRENT OPINION IN IMMUNOLOGY
    66. Ohmine, K; Ota, J; Ueda, M; Ueno, S; Yoshida, K; Yamashita, Y; Kirito, K; Imagawa, S; Nakamura, Y; Saito, K; Akutsu, M; Mitani, K; Kano, Y; Komatsu, N; Ozawa, K; Mano, H
      Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells

      ONCOGENE
    67. Brasher, BB; Roumiantsev, S; Van Etten, RA
      Mutational analysis of the regulatory function of the c-Abl Src homology 3domain

      ONCOGENE
    68. Hoover, RR; Gerlach, MJ; Koh, EY; Daley, GQ
      Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells

      ONCOGENE
    69. Wong, S; Witte, ON
      Modeling Philadelphia chromosome positive leukemias

      ONCOGENE
    70. Peters, DG; Klucher, KM; Perlingeiro, RCR; Dessain, SK; Koh, EY; Daley, GQ
      Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformedhematopoietic cell line that induces leukemia in mice

      ONCOGENE
    71. Lin, F; Monaco, G; Sun, T; Liu, JX; Lin, H; Stephens, C; Belmont, J; Arlinghaus, RB
      BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model

      ONCOGENE
    72. Hernandez-Boluda, JC; Cervantes, F; Alvarez, A; Costa, D; Montserrat, E
      Single-agent therapy with oral mercaptopurine for nonlymphoid blast crisisof chronic myeloid leukemia

      ANNALS OF HEMATOLOGY
    73. Fruehauf, S; Steiger, S; Topaly, J; Ho, AD
      Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemia

      ANNALS OF HEMATOLOGY
    74. Kroger, N; Zabelina, T; Kruger, W; Renges, H; Stute, N; Durken, M; von Finkenstein, FG; Erttmann, R; Kabisch, H; Schafhausen, P; Jaburg, N; Loliger, C; Zander, AR
      Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem celltransplantation from unrelated donors

      ANNALS OF HEMATOLOGY
    75. Kahl, C; Pelz, AF; Bartsch, R; Jentsch-Ullrich, K; Bruckner, R; Fostitsch, HP; Franke, A
      Myeloid/natural killer cell precursor blast crisis of chronic myelogenous leukemia with two Philadelphia (Ph-1) chromosomes

      ANNALS OF HEMATOLOGY
    76. Wakayama, T; Maniwa, Y; Ago, H; Kakazu, N; Abe, T
      A variant form of myelodysplastic syndrome with Ph- minor-BCR/ABL transcript

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    77. Sattler, M; Griffin, JD
      Mechanisms of transformation by the BCR/ABL oncogene

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    78. Maru, Y
      Molecular biology of chronic myeloid leukemia

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    79. Kopp, M; Holzner, B; Brugger, A; Nachbaur, D
      Successful management of claustrophobia and depression during allogeneic SCT

      EUROPEAN JOURNAL OF HAEMATOLOGY
    80. Vindelov, L
      Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)

      EUROPEAN JOURNAL OF HAEMATOLOGY
    81. Thiele, T; Kvasnicka, HM; Beelen, DW; Flucke, U; Spoer, C; Paperno, S; Leder, LD; Schaefer, UW
      Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: An immunohistochemical study of 127 patients

      MODERN PATHOLOGY
    82. Brunstein, CG; McGlave, PB
      The biology and treatment of chronic myelogenous leukemia

      ONCOLOGY-NEW YORK
    83. Schaap, N; Schattenberg, A; Bar, B; Preijers, F; van Kemenade, EV; de Witte, T
      Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donorleukocyte infusions

      LEUKEMIA
    84. Damiano, JS; Hazlehurst, LA; Dalton, WS
      Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation

      LEUKEMIA
    85. Thauvin-Robinet, C; Maingueneau, C; Robert, E; Elefant, E; Guy, H; Caillot, D; Casasnovas, RO; Douvier, S; Nivelon-Chevallier, A
      Exposure to hydroxyurea during pregnancy: a case series

      LEUKEMIA
    86. de Wynter, EA; Heyworth, CM; Mukaida, N; Matsushima, K; Testa, NG
      NOD/SCID repopulating cells but not LTC-IC are enriched in human CD34(+) cells expressing the CCR1 chemokine receptor

      LEUKEMIA
    87. Moravcova, J; Nadvornikova, S; Sieglova, Z; Formankova, R; Krskova, L; Dvorakova, R; Brdicka, R
      Do transcriptionally silent BCR-ABL cells persist in CML patients in molecular remission after stem cell transplantation?

      LEUKEMIA
    88. Shteper, PJ; Siegfried, Z; Asimakopoulos, FA; Palumbo, GA; Rachmilewitz, EA; Ben-Neriah, Y; Ben-Yehuda, D
      ABL1 methylation in Ph-positive ALL is exclusively associated with the P210 form of BCR-ABL

      LEUKEMIA
    89. von Bergh, A; Gargallo, P; De Prijck, B; Vranckx, H; Marschalek, R; Larripa, I; Kluin, P; Schuuring, E; Hagemeijer, A
      Cryptic t(4;11) encoding MLL-AF4 due to insertion of 5 ' MLL sequences in chromosome 4

      LEUKEMIA
    90. Topaly, J; Zeller, WJ; Fruehauf, S
      Synergistic activity of the new ABL-specific tyrosine kinase inhibitor ST1571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells

      LEUKEMIA
    91. Keil, F; Prinz, F; Kalhs, P; Lechner, K; Moser, K; Schwarzinger, I; Jager, U; Fonatsch, C; Worel, N; Mannhalter, C; Rabitsch, W; Loidolt, H; Schulenburg, A; Mitterbauer, M; Hocker, P; Greinix, HT
      Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants

      LEUKEMIA
    92. Thiede, C; Bornhauser, M; Oelschlagel, U; Brendel, C; Leo, R; Daxberger, H; Mohr, B; Florek, M; Kroschinsky, F; Geissler, G; Naumann, R; Ritter, M; Prange-Krex, G; Lion, T; Neubauer, A; Ehninger, G
      Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers

      LEUKEMIA
    93. Yamaguchi, H; Inokuchi, K; Sakuma, Y; Dan, K
      Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia

      LEUKEMIA
    94. Elliott, MA; Dewald, GW; Tefferi, A; Hanson, CA
      Chronic neutrophilic leukemia (CNL): a clinical, pathologic and cytogenetic study

      LEUKEMIA
    95. Kramer, A; Loffler, H; Bergmann, J; Hochhaus, A; Hehlmann, R
      Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia

      LEUKEMIA
    96. Pavithran, K; Thomas, M
      Chronic myeloid leukemia presenting as gout

      CLINICAL RHEUMATOLOGY
    97. Prosper, F; Verfaillie, CM
      Regulation of hematopoiesis through adhesion receptors

      JOURNAL OF LEUKOCYTE BIOLOGY
    98. Wright, L; Kearney, P
      Current status of ribozymes as gene therapy agents for cancer

      CANCER INVESTIGATION
    99. Korbling, M; Giralt, S; Khouri, I; Mirza, N; Donato, M; Anderlini, P; Fischer, H; Andreeff, M; McMannis, J; Champlin, R
      Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis

      JOURNAL OF CLINICAL APHERESIS
    100. Soiffer, RJ; Weller, E; Alyea, EP; Mauch, P; Webb, IL; Fisher, DC; Freedman, AS; Schlossman, RL; Gribben, J; Lee, S; Anderson, KC; Marcus, K; Stone, RM; Antin, JH; Ritz, J
      CD6+donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors

      JOURNAL OF CLINICAL ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 04:55:15